The combined glucose-lowering effects of semaglutide, keto-induced insulin reduction, and any other diabetes medications taken concurrently can produce hypoglycemia, and the situation requires careful monitoring
While adult obesity rates have driven commercial focus, childhood obesity has reached epidemic proportions globally, with limited therapeutic options available for younger patients
20,21 Our previous study found that semaglutide, a novel GLP-1RA, could resist ovarian inflammation through AMPK/SIRT1/NF-B pathway
A combination of glutathione, milk thistle, and zinc contributes to antioxidant support and internal balance
82,83,84 This is particularly evident in triple-negative breast cancer models, where inhibition of diacylglycerol O-acyltransferase (DGAT)-dependent lipid droplet biogenesis redistributes PUFA species from neutral lipid storage pools into membrane phospholipids